“Our Natera offerings are about consumer inclusion, not exclusion. We believe that consumers should be applauded for taking steps to include more plant-based meals into their diet as they transition from their meat diets and our products are created to support those choices with a wide variety of tasty alternatives to meat. Every journey begins with a single step and we are proud to be able to provide products that help consumers take those steps to include more plant-based choices in their diets,” states Naturally Splendid CEO Mr. J. Craig Goodwin.
Whether you’re a carnivore, vegan, or somewhere in between, there is no denying that the plant-based food market has grown substantially in the last few years. According to Grand View Research, the vegan food market is expected to reach USD $24.06 billion by 2025 at a CAGR rate of 9.6%. As awareness of plant-based foods and meat alternatives increases, the global vegan population has grown exponentially as a result. Additionally, a report by the Plant Based Foods Association and The Good Food Institute indicates that retail sales of plant-based foods in the United States grew 27% in 2020, pushing the plant-based market to a value of $7 billion.
Naturally Splendid is preparing to respond to an increasing demand for plant-based foods by placing additional orders with its Australian manufacturer. The Company has seen an increase in demand due to the expansion of its distribution network and a strengthened ecommerce presence. Shipment orders from Australia are expected to arrive in Vancouver and will assist Naturally Splendid in supplying the increasing demand for the Company’s Natera plant-based food products. Keep in mind, North America represented the largest regional market for vegan food products in 2018 and accounted for more than 31% of the overall share. In particular, according to a study conducted by Dalhousie University professor Sylvian Charlesbois, British Columbia accounted for the largest percentage of vegans and vegetarians in Canada.
Say, whatever happened to Naturally Splendid’s Cavaltinib™ COVID-19 treatment? Unfortunately, there have not yet been any updates pertaining to the Company’s Cavaltinib™ clinical trials. This is likely due to the lengthy process of clinical trials, however, the flexible nature of Cavaltinib™ will likely prove to be effective in treating a variety of ailments aside from COVID-19 in the future. With this in mind, as the Company’s clinical trials progress, keeping an eye out for Cavaltinib™ headlines may be worth your while.
Naturally Splendid’s share price has been steadily trading at $0.06 since open. The Company’s share price currently sits at $0.06 as of 10:44AM ET.